-
Safety of Biologic Therapy in Rheumatoid Arthritis CME
How safe are biologic therapies in the treatment of RA? The current review describes the latest evidence on this issue.
October 11, 2011
-
Management of Psoriatic Arthritis From the View of the Dermatologist CME
What is the best practice in the evaluation and management of psoriatic arthritis? The current review addresses these issues.
September 13, 2011
-
Biologic Therapies in Non-rheumatic Diseases: Lessons for Rheumatologists? CME
How effective and safe are biologic therapies for nonrheumatic diseases? The current review evaluates this issue.
August 02, 2011
-
Sarcoidosis-- Scientific Progress and Clinical Challenges CME
Sarcoidosis is a complex illness in which a combination of factors may promote disease. The current review describes these factors as well as current management of sarcoidosis.
July 12, 2011
-
Pathogenesis of Systemic Juvenile Idiopathic Arthritis: Some Answers, More Questions CME
Systemic juvenile idiopathic arthritis has unique mechanisms of disease that clinicians should understand. The current review summarizes the pathophysiology of systemic juvenile idiopathic arthritis.
June 07, 2011
-
Adult Outcomes of Childhood-Onset Rheumatic Diseases CME
How do rheumatic diseases diagnosed and treated during childhood affect adult health? The current review answers this question.
April 12, 2011
-
Pediatric SLE -- Toward a Comprehensive Management Plan CME
Systemic lupus erythematosus can promote high rates of morbidity and mortality among children. The current review highlights how to care for children with SLE.
March 08, 2011
-
Conservative Biomechanical Strategies for Knee Osteoarthritis CME
Can biomechanical treatment strategies help patients with osteoarthritis of the knee? The current review evaluates these interventions.
February 02, 2011
-
Hepatotoxicity Related to Antirheumatic Drugs CME
The current review analyzes the risk for hepatotoxicity associated with the use of antirheumatic drugs, and offers means to prevent liver damage among patients receiving these medications.
January 25, 2011
-
Current View of Glucocorticoid Co-therapy With DMARDs in Rheumatoid Arthritis
What is the role of glucocorticoid treatment in the contemporary management of rheumatoid arthritis? The current review answers this question.
December 01, 2010
-
Muscle Weakness, Afferent Sensory Dysfunction and Exercise in Knee Osteoarthritis
Persons at increased risk for knee OA, such as those with previous knee injuries, can be identified and may benefit from exercise to prevent or delay OA onset.
November 30, 2010
-
ANCA-Associated Vasculitides -- Advances in Pathogenesis and Treatment
What are the latest issues in the understanding of the pathophysiology of ANCA-associated vasculitides and the treatment of these disorders? The current review addresses these issues.
October 05, 2010
-
Inherited Human Diseases of Heterotopic Bone Formation
Inherited human diseases of heterotopic bone formation still lack appropriate therapy to prevent disease. New knowledge about the causes of these illnesses may yield better therapeutic options.
August 10, 2010
-
Assessing Microvascular Changes in Systemic Sclerosis Diagnosis and Management
The current review highlights the diagnosis and treatment of microvascular disease in cases of systemic sclerosis.
August 10, 2010
-
Rheumatoid Cachexia and Cardiovascular Disease
The risk for cardiovascular events and mortality is high among patients with rheumatoid arthritis (RA). This review describes how body composition affects RA and cardiovascular disease.
July 20, 2010
-
Takayasu Arteritis--Advances in Diagnosis and Management
The main challenge associated with Takayasu's disease is correct recognition of the symptoms and signs to include as a differential diagnosis.
July 01, 2010
-
B Cells as Therapeutic Targets in SLE
Selective B-cell depletion has shown promise in the treatment of autoimmune diseases, and improved knowledge of B cells and plasma cells will tap the potential for additional therapeutic strategies.
June 03, 2010
-
Targeted Therapy for Systemic Sclerosis: How Close Are We?
Targeting distinct biological pathways is part of the future of treatment of systemic sclerosis. The current review highlights new therapeutic options for systemic sclerosis.
April 13, 2010
-
Adverse Effects of Chronic Opioid Therapy for Chronic Musculoskeletal Pain
How safe is opioid therapy in the long term management of chronic pain? This activity outlines the efficacy and the potential risks for opioid medications for chronic musculoskeletal pain.
April 01, 2010
-
Management of Glucocorticoid-Induced Osteoporosis
GIO remains underdiagnosed and underrecognized regardless of a growing awareness of osteoporosis and its morbidities and mortality.
February 03, 2010
